Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc. is a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat serious diseases associated with inflammation, autoimmune and cardiovascular conditions. The primary function of Anthera Pharmaceuticals is to focus on advancing late-stage clinical trials and achieving regulatory approvals for its portfolio of biologic and small-molecule drug candidates. The company is actively involved in the biotechnology and healthcare industries, making significant impacts in areas needing innovative treatment options. Founded with a mission to address unmet medical needs, Anthera aims to deliver new treatment avenues for conditions such as systemic lupus erythematosus and acute pancreatitis. The strategic emphasis on rare and complex diseases underscores its market significance, positioning Anthera Pharmaceuticals as a pioneering entity in specialized therapeutic development. By aligning clinical expertise with research capabilities, Anthera contributes dynamically to pharmaceutical advancements, offering potential solutions where limited options exist.